Clarke, Jeffrey Melson
Blobe, Gerard C.
Strickler, John H.
Uronis, Hope Elizabeth
Zafar, S. Yousuf
Morse, Michael
Dropkin, Evan
Howard, Leigh
O’Neill, Margot
Rushing, Christel N.
Niedzwiecki, Donna
Watson, Hollie
Bolch, Emily
Arrowood, Christy
Liu, Yingmiao
Nixon, Andrew B.
Hurwitz, Herbert I.
Funding for this research was provided by:
Pfizer (WI178914)
Article History
Received: 2 July 2019
Accepted: 27 July 2019
First Online: 23 August 2019
Compliance with ethical standards
:
: Jeffrey Clarke, MD Research Funding: Bristol-Myers Squibb, Genentech, Spectrum, Adaptimmune, Medpacto, Bayer, AbbVie, Moderna, Array, Eli Lilly Speaking: Merck Advisory and Consulting: AstraZeneca, Guardant, Merck, Eli Lilly, Achilles Therapeutics (uncompensated) Board of Directors: Lung Cancer Initiative of North Carolina (uncompensated) John Strickler, MD Research Grant Funding: OncoMed, Seattle Genetics, Exelixis, Amgen, Abbvie, Genentech/ Roche, Gilead Sciences, Macrogenics, Leap Therapeutics, Curegenix. Consulting or honoraria: Amgen, AstraZeneca, Bayer, Celgene, Chengdu Kanghong Biotechnology, Genentech/Roche, OncoMed, Proteus Digital Health, Seattle Genetics S. Yousuf Zafar, MD Employment (spouse): Shattuck Labs Advisory Board: AIM Specialty Health, Vivor, LLC (uncompensated), SamFund (Uncompensated) Board of Directors: Family Reach Foundation (uncompensated) Research Funding: NIH, Astrazeneca, Copernicus-WCG IRB Board Member: Copernicus-WCG IRB Consulting: RTC, Messon, Discern LLC, Quintiles Corporation Michael Morse, MD Honoraria: Genentech, Bayer Herbert Hurwitz, MD Employment and Stock Ownership: Genentech Roche Research: Pfizer, Genentech Advisory: Genentech Roche.